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Abstract
Background: Prostate epithelial cells accumulate a high level of aspartate that is utilized as a
substrate for their unique function of production and secretion of enormously high levels of citrate.
In most mammalian cells aspartate is synthesized; and, therefore is a non-essential amino acid. In
contrast, in citrate-producing prostate cells, aspartate is an essential amino acid that must be
derived from circulation. The prostate intracellular/extracellular conditions present a 40:1
concentration gradient. Therefore, these cells must possess a plasma membrane-associated
aspartate uptake transport process to achieve their functional activity. In earlier kinetic studies we
identified the existence of a unique Na+-dependent high-affinity L-aspartate transport process in
rat prostate secretory epithelial cells. The present report is concerned with the identification of
this putative L-aspartate transporter in rat and human prostate cells.
Results: The studies show for the first time that EAAC1 is expressed in normal rat prostate
epithelial cells, in normal and hyperplastic human prostate glands, and in human malignant prostate
cell lines. EAAC1 expression and high-affinity L-aspartate transport are correspondingly down-
regulated by EAAC1 siRNA knock down. Exposure of prostate cells to physiological levels of
prolactin or testosterone results in an up-regulation of EAAC1 expression and a corresponding
increase in the high-affinity transport of L-aspartate into the cells.
Conclusion: This study shows that EAAC1 functions as the high-affinity L-aspartate transporter
that is responsible for the uptake and accumulation of aspartate in prostate cells. In other cells
(predominantly excitable tissue cells), EAAC1 has been reported to function as a glutamate
transporter rather than as an aspartate transporter. The regulation of EAAC1 expression and L-
aspartate transport by testosterone and prolactin is consistent with their regulation of citrate
production in prostate cells. The identification of EAAC1 as the high-affinity L-aspartate
transporter now permits studies to elucidate the mechanism of hormonal regulation of EAAC1
gene expression, and to investigate the mechanism by which the cellular environment effects the
functioning of EAAC1 as an aspartate transporter or as a glutamate transporter.
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Background
Normal prostate secretory epithelial cells have the special-
ized and unique function of synthesizing and accumulat-
ing extraordinarily high levels of citrate for secretion as a
major component of prostatic fluid [for recent reviews of
prostate citrate metabolism see [1-3]]. This requires a con-
tinual availability of carbon sources for the intramito-
chondrial production of acetyl coenzyme A and
oxalacetate for the synthesis of citrate. The former is
derived from glucose via pyruvate formation and oxida-
tion, and the latter is derived from aspartate via transami-
nation with glutamate (mitochondrial aspartate
aminotransferase reaction; mAAT). In these specialized
prostate cells, aspartate is an essential amino acid that is
derived from circulation. As represented in rat ventral
prostate glandular epithelial cells, the cellular concentra-
tion of aspartate is ~1.2 mM [4-6]. The plasma level of
aspartate is ~0.03 mM. Therefore the uptake and accumu-
lation of cellular aspartate occurs against a 40:1 concen-
tration gradient. This is achieved by the existence of a
Na+-dependent high-affinity L-aspartate transport process
with kinetic properties that result in cellular accumulation
of aspartate from circulation [5-7]. The kinetic properties
are representative of the Na+- dependent high-affinity
glutamate-aspartate transporters referred to as the XAG
-
class of amino acid transporters. The general characteris-
tics of this class include: plasma membrane transporters;
transport either glutamate or aspartate with high affinity;
Na+ coupled transport; no or low affinity for neutral and
basic amino acids [8,9].
An important unresolved issue was the identification of
the putative prostate high-affinity L-aspartate transporter.
Subsequent to our kinetic identification of the transport
process, significant advances have been achieved in the
genetic and protein identification and characterization of
the XAG
- transporter class as EAATs (excitatory amino acid
transporters). This class includes EAAT1 (GLAST1);
EAAT2 (GLT1); EAAT3 (EAAC1); EAAT4. The dominance
of the reported studies in excitatory cells has resulted in
the EAATs being described functionally as glutamate
transporters. Nevertheless, we focused on the possibility
that a member of this class of transporters, particularly the
ubiquitously expressed EAAC1, could be the functional
high-affinity L-aspartate transporter in prostate cells. Our
earlier studies (6) demonstrated that the high-affinity
transport of aspartate is regulated by testosterone, which
appeared to be dependent upon its regulation of gene
expression of a putative transporter. In this present report
we show that EAAC1 (Primary accession number P43005;
gene SLC1A1) is expressed in normal rat prostate epithe-
lial cells, in human prostate glandular tissue, and in
human prostate malignant cell lines; and EAAC1 func-
tions as a high-affinity L-aspartate transporter in rat and
human prostate cells; and EAAC1 expression is regulated
by testosterone and prolactin.
Results
In the absence of published information regarding the
identification of specific aspartate transporters in prostate,
we elected to determine if any members of the EAAT class
were expressed in prostate cells. Because we had identified
the high-affinity L-aspartate transport process in rat ven-
tral prostate cells [5-7], we first determined the expression
(RT-PCR) of EAATs in these cells; and, for comparison, in
brain tissue that is known to express these transporters. As
shown in figure 1, EAATs 1–4 are expressed in brain tissue
as expected. In rat ventral prostate cells: EAAT 4 is not
expressed; EAAT 1 and EAAT 2 seem to be weakly
expressed. Most importantly, EAAC1 is prominently
expressed in the ventral prostate cells. This led us to expect
that EAAC1 might be the functional high-affinity L-aspar-
tate transporter in prostate cells.
The establishment of EAAC1 as the functional high-affin-
ity L-aspartate transporter requires the demonstration that
altered expression of EAAC1 results in altered aspartate
uptake. In order to determine this relationship we elected
to employ the human prostate PC-3 cell line. However, it
was necessary to determine if PC-3 cells exhibit aspartate
uptake under the conditions representative of the high-
affinity L-aspartate transport that we had established in rat
ventral prostate cells. As shown in figure 2, PC-3 cells
exhibit high-affinity L-aspartate uptake. We also deter-
mined if PC-3 cells contained membrane-associated
EAAC1, and figure 2 establishes the presence of EAAC1
transporter protein. These relationships in the PC-3 cells
made it possible to determine the effect of EAAC1 knock-
down on the abundance of EAAC1 transporter and on the
high-affinity transport of aspartate. Figure 2 shows that
the abundance of EAAC1 transporter is effectively down-
regulated in siRNA transfected PC-3 cells. Since siRNA(5)
appeared to be more effective than siRNA(3) subsequent
experiments were carried siRNA(5). Correspondingly, the
results demonstrate that knock-down of EAAC1 markedly
decreases the high-affinity uptake of aspartate by PC-3
cells. The specificity of the siRNA for EAAC1 is demon-
strated by the absence of knock-down of EAAT1 that is
also expressed in these cells. It is evident that some aspar-
Expression of EAATs (RT-PCR) in rat brain and in rat ventral  prostate cells Figure 1
Expression of EAATs (RT-PCR) in rat brain and in rat ventral 
prostate cells.BMC Biochemistry 2006, 7:10 http://www.biomedcentral.com/1471-2091/7/10
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tate transport activity remains after siRNA knock-down of
EAAC1. This residual activity is likely partly due to some
existing low level of EAAC1, and also due to some addi-
tional aspartate transport mechanism that we earlier
described as low-affinity transport [5]. Nevertheless, the
major point is the demonstrated down regulation of
EAAC1 along with significant reduction of aspartate trans-
port.
An earlier report [6] demonstrated that testosterone
increased the high-affinity transport of aspartate in the rat
ventral prostate cells. Therefore we surmised that, if
EAAC1 is the high-affinity transporter in prostate cells,
testosterone treatment should be expected to increase the
expression of EAAC1 in these cells. Figure 3 shows that
exposure of the ventral prostate cells to testosterone
results in a >100% increase in the level of EAAC1 trans-
porter. This correlates with our earlier study of testoster-
one stimulation of high-affinity L-aspartate uptake in the
prostate cells.
In addition to testosterone, prolactin also regulates citrate
production and key metabolic genes, including mAAT
gene expression [[3], for review]; which caused us to con-
sider the possibility that prolactin might also be impor-
tant in the regulation of aspartate transport. Therefore, the
effect of prolactin was determined, along with testoster-
one, on the high-affinity L-aspartate transport in the rat
ventral prostate cells. In this study, the donor rats were
Effects of EAAC1 siRNA on EAAC1 expression and aspar- tate uptake by PC-3 cells Figure 2
Effects of EAAC1 siRNA on EAAC1 expression and aspar-
tate uptake by PC-3 cells. A. The specificity of the 
EAAC1siRNA is demonstrated by the absence of any effect 
on EAAT1. B. EAAC1 siRNA knocks down the level of 
EAAC1 in the membrane fraction of PC-3 cells. Na/K 
ATPase used as a membrane protein for loading control. 
siRNA(3) and siRNA(5) are 2 siRNA pool preparations based 
on difference sequences of EAAC1. C. Specific knock- down 
of EAAC1 decreases high-affinity uptake of aspartate by PC-3 
cells
Effect of testosterone on EAAC1 Figure 3
Effect of testosterone on EAAC1. A. Freshly prepared rat 
ventral VP epithelial cells were incubated for 3 hours in HBSS 
medium that contained 1 nM testosterone or vehicle (con-
trol). Loading gel (not shown) showed no loading differences 
between the control and testosterone samples. B. Effects of 
prolactin and testosterone on high-affinity aspartate trans-
port of rat ventral prostate. The cells were harvested from 
donor animals that were castrated and bromocryptine-
treated to reduce endogenous levels of hormones. CHX= 30 
uM cyclohexamide; PRL= 1 nM; TEST= 10 nM. * P < 0.05 vs 
control.BMC Biochemistry 2006, 7:10 http://www.biomedcentral.com/1471-2091/7/10
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castrated and bromocryptine-treated to minimize effects
of endogenously produced hormones. The results (figure
3) show that prolactin and testosterone significantly
increase the high-affinity transport of aspartate by 180%
and 140%, respectively. Moreover, treatment with
cyclohexamide attenuates the stimulatory effect of prolac-
tin and testosterone; thereby indicating the dependency of
the hormonal effects on gene expression. The effects of
testosterone corroborate our earlier report [6]. Based on
this observation, we determined the effect of prolactin on
the expression of EAAC1 and correspondingly on aspar-
tate transport in normal rat ventral prostate epithelial
cells. Figure 4 shows that prolactin treatment increases the
level of EAAC1; and correspondingly increases the uptake
of aspartate. It is important to note that the level of hor-
monal stimulation is less than shown in figure 3, which is
a reflection of the endogenous hormonal effect in the nor-
mal animals [4]. Previous studies have shown that prolac-
tin regulation of metabolic genes in prostate cells is
mediated via direct stimulation of the PKC signalling
pathway and is mimicked by phorbol ester [3]. For this
reason we also determined the effects of TPA (12-O-tetra-
decanoylphorbol-13-acetate). The stimulation of EAAC1
and aspartate transport by TPA as well as by prolactin is
indicative of the involvement of PKC in the regulation of
the EAAC1 gene (which we are now studying). These
results further corroborate the relationship between
EAAC1 and high-affinity L-aspartate transport in prostate
cells, and also establish that prolactin as well as testoster-
one is involved in the hormonal regulation of EAAC1.
We were fortunate to obtain some archived human pros-
tate tissue samples (courtesy of Dr. John Kurhanewicz,
UCSF), which we analyzed for EAAC1 expression. At the
same time we determined the expression of EAAC1 in
LNCaP, DU-145, and PC-3 cells. Figure 5 shows that
EAAC1 is expressed in human normal and hyperplastic
glandular tissue as well as in the three malignant cell lines.
Thus EAAC1 expression seemingly is ubiquitous in rat and
human prostate cells.
Discussion
The present studies establish that alterations in the expres-
sion and level of EAAC1 transporter by siRNA knock-
down or by hormonal stimulation are consistently accom-
panied by corresponding alterations in the high-affinity
transport of aspartate. These studies in concert with our
earlier reports [5-7] establish that EAAC1 is the functional
transporter that is responsible for this high-affinity L-
aspartate transport in rat and human prostate cells. This
Effect of PRL and TPA on membrane-associated EAAC1 level  and on L-aspartate uptake by normal rat ventral prostate  cells Figure 4
Effect of PRL and TPA on membrane-associated EAAC1 level 
and on L-aspartate uptake by normal rat ventral prostate 
cells. Prolactin (PRL) concentration was 1 nM and TPA con-
centration was 0.1 µg/ml for 3 hr. *= p < 0.05 compared to 
control (CRL).
The expression of EAAC1 in human prostate glandular tissue  and in human prostate cell lines Figure 5
The expression of EAAC1 in human prostate glandular tissue 
and in human prostate cell lines. BPH=benign prostatic 
hyperplasia.BMC Biochemistry 2006, 7:10 http://www.biomedcentral.com/1471-2091/7/10
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provides the physiological function for cellular accumula-
tion of aspartate from circulation as is needed for their
specialized function of net production of high levels of cit-
rate. In these cells, aspartate is an essential amino acid that
must be derived from circulation. The aspartate trans-
porter Km ~10 uM aspartate (compared to 30 uM aspar-
tate concentration in plasma) and other kinetic properties
described earlier [5-7] provide for aspartate uptake and
cellular accumulation against the existing 40:1 concentra-
tion gradient (intracellular: interstitial fluid) across the
cell membrane. In addition, in the presence of a plasma
concentration of 25 uM glutamate [10], the high affinity
uptake of aspartate still occurs at greater than 50% of its
maximal rate [6]. The enhancement of the high-affinity L-
aspartate transport by the trans-stimulatory effect of high
intracellular citrate provides additional effectiveness of
the transporter for aspartate uptake by the prostate cells
[7]. The importance of aspartate and EAAC1 as the high-
affinity L-aspartate transporter in the unique function and
citrate-related intermediary metabolism of prostate cells is
depicted in figure 6.
The role of aspartate and aspartate transport in the pathway of prostate citrate production Figure 6
The role of aspartate and aspartate transport in the pathway of prostate citrate production. Aspartate via mAAT provides the 
four-carbon source of oxalacetate that condenses with acetyl coA for citrate synthesis. The oxidation of citrate via the Krebs 
cycle is prevented by the inhibition of m-aconitase by zinc. The utilized aspartate is replenished by the transport of aspartate 
from interstitial fluid by the EAAC1 aspartate transporter. Note the extremely high concentration of citrate in prostatic fluid 
secretion that requires a substantial and continuous supply of aspartate. mAAT = mitochondrial aspartate aminotransferase; 
GDH = glutamic dehydrogenase; CS = citrate synthase; ACON = mitochondrial aconitase; PDH = pyruvate dehydrogenase.BMC Biochemistry 2006, 7:10 http://www.biomedcentral.com/1471-2091/7/10
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The present study provides the first report of EAAC1
expression in prostate cells. More importantly, this report
coupled to earlier studies [5-7] provides (to the best of our
knowledge) the first definitive identification of EAAC1 as
a preferential functional L-aspartate transporter. The oper-
ation of EAAC1 as a high-affinity L-aspartate transporter
in prostate cells differs from its dominant focus as a gluta-
mate transporter in excitatory cells. As such, the kinetic
properties of EAAC1 as a high-affinity L-aspartate trans-
porter have not been established for other mammalian
cells. King et al [11] reported that L-aspartate uptake in
heart myocytes is mediated by a high affinity sodium-
dependent transporter (Km ~7 uM aspartate), and sug-
gested that the transport might be associated with the
expression in heart of EAAC1. Similarly, mammary cells
reportedly express an XAG
- transporter that exhibits a sig-
nificantly higher affinity for aspartate (Km = 32 uM) than
for glutamate (Km = 112 uM); thereby potentially demon-
strating a selectivity for aspartate transport [12]. In an
analogous situation, Besson et al [13] reported that the
nervous tissue-specific Drosophila EAAT2 preferentially
functions as a Na+-dependent high-affinity aspartate
transporter
The in situ operation and preference of plasma mem-
brane-associated EAAC1 either as a high-affinity gluta-
mate transporter or as a high-affinity aspartate transporter
is determined by the intracellular and extracellular envi-
ronment of the cell, and by the functional/metabolic
activities of the cell. Unlike prostate cells, most mamma-
lian cells synthesize aspartate and have no requirement
for the extraction of aspartate from circulation. Moreover,
glial cells and central neurons operate in the environment
of cerebrospinal fluid and localized synaptic junctions
that have a much different milieu composition than the
common interstitial fluid environment of most cells. Even
among cells that are exposed to the same interstitial fluid
environment, the activity of plasma membrane transport-
ers can differ as a result of differences in the intracellular
activity and composition. This is particularly illustrated by
the pronounced trans-stimulatory effect (11-fold increase
in aspartate transport) of the high intracellular citrate con-
centration that exists in prostate cells but not in other
mammalian cells [7]. Therefore, it is not surprising that
EAAC1 shows variability in different cells in its functional
preference for aspartate transport or for glutamate trans-
port.
The effect of testosterone and prolactin on EAAC1 and
high affinity L-aspartate transport has two important
implications. As already discussed, the hormonal up-reg-
ulation of EAAC1 and corresponding increase in aspartate
transport provide evidence that EAAC1 is the functional
high-affinity L-aspartate transporter. Another implication
relates to the regulation of the major prostate function of
citrate production and secretion into prostatic fluid. Both
hormones regulate (increase) prostate citrate production.
They do so by regulation of gene expression of key regula-
tory enzymes in the pathway of citrate metabolism; pyru-
vate dehydrogenase, mAAT and m-aconitase [3]. The
present report adds the EAAC1 transporter gene (SLC1A1)
expression as a key step in the pathway to net citrate pro-
duction. This is consistent with the regulation of mAAT
gene expression; so that the aspartate substrate does not
become limiting for the enzyme reaction in the direction
of OAA production for citrate synthesis (figure 6). We
have shown that prolactin regulation of mAAT gene
expression is mediated via the diacylglycerol→ PKCepsi-
lon → AP-1 signaling pathway (3,14,15). The stimulation
of EAAC1 expression by both prolactin and TPA suggests
that this PKC pathway is involved in regulation of the
SLC1A1  gene, which we are now studying. Millar and
Shennan [12] reported that treating lactating rats with
bromocryptine reduced D-aspartate uptake by mammary
tissue explants and suggested that the transport of anionic
amino acids by the rat mammary gland is regulated by
prolactin. It is of interest that phorbol ester activation of
select PKC isoforms in some cells causes increased associ-
ation of subcellular EAAC1 with the plasma membrane;
which increases glutamate transport [16-18]. Whether or
not such a mechanism applies to EAAC1 and aspartate
transport in prostate cells needs to be investigated.
Conclusion
Aspartate uptake and utilization are essential require-
ments for the unique function of production and secre-
tion of extraordinarily high levels of citrate by prostate
epithelial cells. To achieve this, these cells posses a high-
affinity L-aspartate transporter that serves to extract aspar-
tate from circulation. We now show that EAAC1 is
expressed in human and rat prostate cells and functions as
the high-affinity L-aspartate transporter in prostate cells.
The expression of EAAC1 and the corresponding high-
affinity transport of aspartate are up-regulated by testo-
sterone and by prolactin, which correlates with the hor-
monal regulation of prostate citrate production. EAAC1
provides the high-affinity transporter for prostate cell
uptake and accumulation of aspartate from circulation,
which provides the source of OAA that is essential for the
synthesis and secretion of extraordinarily high levels of
citrate. The identification of EAAC1 as the aspartate trans-
porter now permits studies of the SLC1A1 gene for identi-
fication of the mechanism of testosterone and prolactin
regulation, and permits studies of the kinetic relationships
and mechanisms of preferential and enhanced aspartate
transport by EAAC1 in prostate and other cells. Moreover,
the identification of EAAC1 in human normal and hyper-
plastic glandular tissue raises the need to determine its
expression in prostate adenocarcinomatous glands; and
such a study is in progress.BMC Biochemistry 2006, 7:10 http://www.biomedcentral.com/1471-2091/7/10
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Methods
Preparation of prostate cells and hormone treatment
The animals used in these studies were maintained in
accordance with the NIH guidelines for the care and use
of laboratory animals. In experiments that involved the
effects of hormone, 8–10 animals were castrated over
night to reduce endogenous androgen levels or treated
with bromocryptine (Sigma Aldrich) to reduce the endog-
enous level of prolactin as previously described [14,19].
Twenty-four hours after castration or bromocryptine treat-
ment, prostate tissue was resected and isolated ventral
prostate cells prepared by collagenase digestion as previ-
ously described [14]. Cells were then incubated with tes-
tosterone (10-8 M), prolactin (10-9 M) or TPA for 3 hours
based on our previous studies [6,15]. Cells were collected,
washed and used for L-aspartate uptake assay or Western
blot analysis. Controls were treated with the appropriate
vehicle. Each experiment was repeated at lease two times
with triplicate samples for each data point. Data are
shown as mean and s.e.m.
High affinity L-aspartate uptake assay
The preparation of freshly isolated rat ventral prostate epi-
thelial cells and the conditions for high-affinity L-aspar-
tate transport are detailed in our previous reports [5-7].
Transport was conducted by adding 50 ul of cell suspen-
sion (106 cells) to 1.0 ml Tris-Na+ medium containing 3H-
labelled L-aspartate at a final concentration of 30 uM
which is the plasma concentration of L-aspartate. Uptake
was conducted for either 1 min and 5 min or 1 min and
10 min at 37°C to ensure that the 1 min uptake was dur-
ing a linear phase of uptake. After the uptake incubation
the cells were rapidly washed, collected on filters and
counted in a liquid scintillation counter. All assays were
run in triplicate and the mean +/- SEM determined for t-
test statistical analyses.
Cell culture and siRNA treatment
PC-3 cells were obtained from the American Type Culture
Collection (ATCC, Manassas, VA). The cells were cultured
in RMPI 1640 medium supplemented with 10% fetal
bovine serum, 50 units/ml penicillin and 50 mg/ml strep-
tomycin as previously described [14]. Cells were treated in
6 well plates with siGENOME EAAC1 Smart Pool siRNA
from Dharmacon RNA Technologies. Initial experiments
showed that Smart Pool sequences 3 and 5 resulted in the
most knock-down of EAAC1 expression; therefore subse-
quent experiments were carried out using sequence 5. The
sequence of siRNAs 3 and 5 were 5'-GGAAGAUCAUA-
GAAGUUGAUU-3' and 5'-GCUGAUAUAUUU-
CAUAGUCUU-3' respectively. Cells were transfected with
20 nM/well siRNA using TransIT-TKO (Mirus) reagent
according to the manufacture's protocol. After 72 hrs cells
were collected washed and lysates prepared for Western
blot analysis or cells were used for assay of high-affinity L-
aspartate transport as described above for rat ventral pros-
tate cells. Analysis of EAAT1 expression showed that the
siRNA treatment was specific for EAAC1.
Western Blot for aspartate transporters
The membrane fraction was prepared from whole cell
lysates as we have previously described [14]. Extracted
membrane proteins were separated by SDS-PAGE, trans-
ferred to nitrocellulose membrane and probed using spe-
cific antibodies for EAAC1 and EAAT1 purchased from
Alpha Diagnostics International. Membranes were incu-
bated with a 1 to 1000 dilution of primary antibody fol-
lowed by incubation with anti-rabbit IgG horseradish
preoxidase linked secondary antibody. Protein bound
antibody was detected using ECL detection reagents from
Amersham Cooperation. Membrane Na/K ATPase used as
a control for loading membrane proteins was detected
using an antibody from Sigma Aldrich. Western blots were
quantified by scanning the film and analyzing the inten-
sity of bands using SigmaScan software.
RT-PCR for aspartate transporters
Total RNA was extracted from rat ventral prostate and
brain tissue using TRIzol Reagent (Invitrogen, Carlsbad
CA). Two µg of total RNA were reverse transcribed using a
TaqMan Gold RT-PCR Kit (Applied Biosystems). Final
reaction concentrations were as follows: 2.5 µmol/L ran-
dom hexamer, 1.25 U/µL Multiscribe reverse tran-
scriptase, 1X TaqMan buffer, 0.4 U/µL RNase inhibitor,
5.5 mmol/L MgCl2, and 500 µmol/L each dNTP. Reverse
transcription was conducted at 25°C for 10 min, 48°C for
30 min, and 95°C for 5 min. An aliquot of 2.5 µl of the
synthesized cDNA served as the PCR template. The condi-
tions for PCR amplification were as follows: 94°C for 3
min; 40 cycles of 94°C for 1 min, 57°C for 1 min, 72°C
for 1 min. Primers for EAAC1, EAAT1, EAAT2 and EAAT4
were: 5'-GTCATTCTGCCAATTAT-3' and 5'-GAT-
GCCGTCTGACAG-3'; 5'-GATTTGCCCTCCGACCGTAT-3'
and 5'-ATGTTTCCAATCACGAAGCC-3'; CTCACTGACT-
GTGTTTGGTG-3' and 5'-CTAAGACATTCATCCCGTCC-
3'; 5'-CGAGTGGTAACAAGGACGAT-3' and 5'-GTTCCGT-
GTGACAAGG-3', respectively.
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